Publication | Closed Access

Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV

Medicinal ChemistryAntibacterial EvaluationMedicineDrug DiscoveryTopoisomerase IvQuinoline-1,2,4-triazole HybridsAntimicrobial CompoundDrug DevelopmentPharmacologyAntiviral CompoundPharmaceutical ChemistryBiomolecular EngineeringDrug Resistance